Page 5 - Read Online
P. 5

Journal of Cancer Metastasis and Treatment
               CONTENTS







               Topic: How does the prostate cancer microenvironment affect the metastatic
               process and/or treatment outcome?


               1           Getting better at treating prostate cancer: what clinicians should want from scientists
                            Malcolm Mason
                            J Cancer Metastasis Treat 2017;3:271-7  http://dx.doi.org/10.20517/2394-4722.2017.51


               2           Getting closer to prostate cancer in patients - what scientists should want from clinicians
                            Norman J. Maitland
                            J Cancer Metastasis Treat 2017;3:262-70  http://dx.doi.org/10.20517/2394-4722.2017.23


               3           Tumor heterogeneity and therapy resistance - implications for future treatments of prostate cancer
                            Fiona M. Frame, Amanda R. Noble, Sandra Klein, Hannah F. Walker, Rakesh Suman,
                            Richard Kasprowicz, Vin M. Mann, Matt S. Simms, Norman J. Maitland
                            J Cancer Metastasis Treat 2017;3:302-14  http://dx.doi.org/10.20517/2394-4722.2017.34


               4           Prostate cancer exosomes as modulators of the tumor microenvironment
                            Alex P. Shephard, Vincent Yeung, Aled Clayton, Jason P. Webber
                            J Cancer Metastasis Treat 2017;3:288-301  http://dx.doi.org/10.20517/2394-4722.2017.32


               5           HOX transcription factors and the prostate tumor microenvironment
                            Richard Morgan, Hardev S. Pandha
                            J Cancer Metastasis Treat 2017;3:278-87  http://dx.doi.org/10.20517/2394-4722.2017.31

               6           Androgen-AR axis in primary and metastatic prostate cancer: chasing steroidogenic enzymes for
                            therapeutic intervention
                            Agnese C. Pippione, Donatella Boschi, Klaus Pors, Simonetta Oliaro-Bosso, Marco L. Lolli
                            J Cancer Metastasis Treat 2017;3:328-61  http://dx.doi.org/10.20517/2394-4722.2017.44


               7           Membrane-type matrix metalloproteinases: expression, roles in metastatic prostate cancer
                            progression and opportunities for drug targeting
                            Robert A. Falconer, Paul M. Loadman
                            J Cancer Metastasis Treat 2017;3:315-27  http://dx.doi.org/10.20517/2394-4722.2017.40


               8           Current challenges and opportunities in treating hypoxic prostate tumors
                            Declan J. McKenna, Rachel Errington, Klaus Pors
                            J Cancer Metastasis Treat 2018;4:11  http://dx.doi.org/10.20517/2394-4722.2017.54
   1   2   3   4   5   6   7   8   9   10